# Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy

> **NCT04152434** · — · COMPLETED · sponsor: **Clinique des Céphalées de Montréal** · enrollment: 158 (actual)

## Conditions studied

- Refractory Chronic Migraine

## Interventions

- **DRUG:** Erenumab Auto-Injector

## Key facts

- **NCT ID:** NCT04152434
- **Lead sponsor:** Clinique des Céphalées de Montréal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2019-07-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04152434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04152434, "Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04152434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*